Phase II Study of Everolimus in Refractory Testicular Germ Cell Cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Testicular cancer
- Focus Therapeutic Use
- 11 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Jun 2015 Primary endpoint has not been met. (Response rate), according to an abstract presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Results (n=15) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.